• Ahmed Baker A Alshaikh Department of Obstetrics & Gynecology, College of Medicine, Jouf University, Sakaka, Kingdom of Saudi Arabia
  • Muhannad Faleh Alanazi Department of Internal Medicine, Division of Radiology, College of Medicine, Jouf University, Sakaka, Saudi Arabia


Pregnancy, Gestational hypertension, polycystic ovary syndrome


The present study intends to identify the factors of the risk of pregnancy with associated gestational hypertension and
polycystic ovarian syndrome compared with normal pregnancy. The retrospective case-control study was conducted
under the Obstetric Department of Maternity and Children Hospital (MCH) Sakaka, Aljouf Saudi Arabia, between
January 2020 to December 2021 including target participants of 192 pregnant women. To identify the risk factors of
pregnancy with associated gestational hypertension and polycystic ovarian syndrome by the method of logistic
regressions. Analysis of data on a total of 192 pregnant women divided into 54 pregnant women associated with
gestational hypertension and polycystic ovarian syndrome as a case group and 138 normal pregnant women in a control
group. We identified risk factors such as body mass index, family history of hypertension and gestational hypertension,
history of pregnancy complications, and history of use of the contraceptive pill, which was significantly found in the
case group compared to controls (p < 0.05). Meanwhile, the family history of diabetes and multiple pregnancies has no
significance between them (p > 0.05). The logistic regression of Age ? 28y(OR2.047, 95 %CI1.122 ~ 3.209), BMI ? 24
kg/m2 (OR1.465, 95 %CI1.070 ~ 2.014), family history of hypertension(OR2.131, 95 %CI1.095 ~ 3.047), the history of
pregnancy complication (OR2.439, 95 %CI1.271 ~ 4.091), history of use contraceptive pills (OR3.810, 95 %CI1.174 ~
6.106), family history of GH(OR1.938, 95 %CI1.015 ~ 2.777) were present in a case group that considered at ( p < 0.05).
In PCOS women, the risk of gestational hypertension is comparatively high. These risk factors are decreased by
definitive preconception treatment for polycystic ovarian syndrome in order to prevent gestational hypertension from
developing early.


Bjekic-Macut J, Vukasin T, Velija-Asimi Z, Burekovic A, Zdravkovic M, Andric Z, Brankovic M, Crevar-Marinovic S, Madic T, Stanojlovic O et al: Polycystic ovary syndrome: a contemporary clinical approach. Curr Pharm Des. 2021; 16:18–26.

Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism. 2005; 90(4):1929-1935.

Okoroh EM, Hooper WC, Atrash HK, Yusuf HR, Boulet SL. Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008. American Journal of Obstetrics and Gynecology. 2012; 207(5):377-e1-8.

S. M. Sirmans and K. A. Pate, “Epidemiology, diagnosis, and management of polycystic ovary syndrome,” Clinical Epidemiology, vol. 6, no. 1, pp. 1–13, 2013.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility. 2004; 81(1):19-25. Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020;30(7):399–404.

Bagatell CJ, Bremner WJ. Androgens in men – uses and abuses. N Engl J Med 1996; 334:707–14.

Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obesity 2002;26(7):883–96

Shu Zhou , Yiping Ji and Haimei Wang. The risk factors of gestational hypertension in patients with polycystic ovary syndrome: a retrospective analysis. Zhou et al. BMC Pregnancy and Childbirth (2021) 21:336

Diane Schneider,1 Joel R. Gonzalez,2 Miya Yamamoto,3 Jingrong Yang,2 and Joan C. Lo. The Association of Polycystic Ovary Syndrome and Gestational Hypertensive Disorders in a Diverse Community-Based Cohort. Journal of Pregnancy Volume 2019, Article ID 9847057.

Bird ST, Hartzema AG, Brophy JM, Etminan M, Delaney JA. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. Canadian Medical Association Journal. 2013

Ali AT. Polycystic ovary syndrome and metabolic syndrome. Ceska Gynekol. 2015;80(4):279–89.

J. Z. Qin, L. H. Pang, M. J. Li, X. J. Fan, R. D. Huang, and H. Y. Chen, “Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis,” Reproductive Biology and Endocrinology, vol. 11, no. 56, 2013.

C. M. Boomsma, M. J. C. Eijkemans, E. G. Hughes, G. H. A. Visser, B. C. J. M. Fauser, and N. S. Macklon, “A metaanalysis of pregnancy outcomes in women with polycystic ovary syndrome,” Human Reproduction Update, vol. 12, no. 6, pp. 673– 683, 2006.

L. E. Kjerulf, L. Sanchez-Ramos, and D. Dufy, “Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis,” American Journal of Obstetrics & Gynecology, vol. 204, no. 6, pp. 558.e1–558.e6, 2011.

Stovall DW, Bailey AP, Pastore LM. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome. J Womens Health (Larchmt). 2011;20(1):37–43.

Liang P, Xi L, Shi J, Li W, Zhao S, Deng Y, Wang R, Sun Y, Gu B, Yuan L, et al. Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome. Fertil Steril. 2017; 107(4):1048–54.




How to Cite

Alshaikh, A. B. A., & Alanazi, M. F. (2023). ASSOCIATED RISK FACTORS OF PREGNANCY WITH GESTATIONAL HYPERTENSION IN POLYCYSTIC OVARIAN SYNDROME WOMAN. Malaysian Journal of Public Health Medicine, 23(3), 22–27. Retrieved from